Asbestos — the foundational mass tort, the §524(g) trust template, the asbestos↔talc convergence, and the contested double-dipping / EPA-ban fights

Built 2026-06-24 from research/spec-asbestos-mass-tort.json. The origin of the mass-tort + liability-engineering lineage. Companion to spec-jj-talc-texas-two-step (Liability_Engineering, Talc_Litigation), spec-opioid-crisis (SCOTUS), spec-pfas-forever-chemicals, EPA, Camp Lejeune.

Frame. Johns-Manville's 1982 bankruptcy birthed the §524(g) trust system (1994) — the legitimate, court-supervised version of liability containment that the later abuses (J&J two-step, DuPont→Chemours spinoff, Purdue/Sackler releases) descend from. Four strands: §524(g) trusts; the asbestos↔talc convergence; the contested double-dipping debate; the 2024 EPA ban + 2025 reconsideration. Discipline. Trusts/§524(g)/Manville/claim counts/the ban = fact. The double-dipping question and the EPA-ban status are reported divergently — both given with dates (per the present-conflicting-sources rule). Dignified victim framing. Overlay; excluded from the proofs.

1. The §524(g) template (the legitimate original)

Johns-Manville (largest asbestos maker) filed Chapter 11 in 1982; the Manville Trust became the precedent for the §524(g) amendment (1994), which channels all current AND future claims into a court-confirmed trust (with a future-claimants' representative) so the debtor emerges clean. Today 60+ active §524(g) trusts hold ~$30–35B. This is the consensual, court-supervised template — the opposite of the J&J Texas two-step (a solvent parent bankrupting a shell). Fact.

2. The asbestos↔talc convergence

In 2025, ~2,035 mesothelioma claims (>99% settle; meso ≈ 48% of asbestos suits), and ~40% of meso suits now allege talc (asbestos-contaminated talc) — directly linking asbestos to the J&J talc litigation. A Dec-2025 Maryland jury awarded $1.5B (peritoneal mesothelioma from J&J talc) — among the largest talc verdicts, and a reason J&J's (failed) bankruptcy-containment attempts mattered so much. Fact.

3. The double-dipping debate (both sides, with dates)

• (A) Industry / tort-reform (US Chamber ILR, ATRA, ~2014→): the two-tier system (sue solvent defendants in court and file with bankruptcy trusts) enables "double-dipping"/fraud; 17 states (since Georgia 2007) passed trust-transparency laws; the federal FACT Act was repeatedly proposed.
• (B) GAO / plaintiff bar: a GAO study identified no fraudulent claim, and advocates argue multi-trust recovery is legitimate (victims were genuinely exposed to many products); the FACT Act would delay/deny dying claimants.

Weight: "double-dipping is rampant fraud" is an assertion the GAO did not substantiate; that multi-source recovery occurs is undisputed — what's disputed is whether it's fraud or legitimate. Both retained. Transparency laws + GAO finding fact; "fraud" framing contested.

4. The EPA chrysotile ban (both sides, with dates)

• (A) Ban (Mar 2024): EPA finalized a ban on ongoing uses of chrysotile asbestos (the only form still used/imported in the US) under TSCA — historic.
• (B) Reconsideration (2025): the Fifth Circuit granted an abeyance giving EPA ~6 months to reconsider amid legal challenges; EPA signaled it may revisit/weaken it (ADAO "alarm").

As of the dated record: finalized-but-under-reconsideration — the same regulate-then-reconsider pattern as the PFAS rollback. Both the 2024 rule and the 2025 abeyance are fact.

5. The honest reading

Asbestos is the template case: §524(g) is the legitimate, court-supervised way to compensate current+future victims from an insolvent defendant — and exactly the model the later abuses mimic without the insolvency or the court's consent. The harm is real and ongoing (meso still kills; the tort is converging on talc). Two genuine disputes stay unsettled and are presented both-ways-with-dates: whether multi-trust recovery is fraud (industry) or legitimate (GAO/plaintiffs), and whether the 2024 chrysotile ban survives reconsideration.

Sources: §524(g) trust list (~$30-35B); Johns-Manville trust; KCIC 2025 — talc-meso rising; EPA — 2024 asbestos ban; Ogletree — 2025 Fifth-Circuit abeyance; ILR — double-dipping (industry); CenterJD — opposing FACT Act (GAO/plaintiff).

← Research index · structured data: spec-asbestos-mass-tort.json · spec-asbestos-mass-tort.md